Analytics
Amprion CEO Russ Lebovitz says proteins in the brain can misfold and form particles that spread from cell to cell, triggering neurodegenerative diseases. A test can identify these proteins, allowing for early diagnosis before symptoms appear.
HIMSS25
Jonathan French, HIMSS' senior director of public policy, lays out the key points of HIMSS' response to the White House's request for information from the public on developing an AI action plan.
The health insurer unintentionally exposed the personal data of 4.7 million people to Google through a misconfigured analytics tool used between 2021 and 2024.
The community-based program targets to screen 260,000 women.
HIMSS25
Generative AI tools can aid non-analyst healthcare staff in gleaning insights from data, but Bruno Lempernesse, MDClone's president, recommends defining guardrails for these tools' use to build trust and protect patient privacy.
The company claims the acquisition will strengthen its AI-enabled platform, improve care gap management and promote collaboration to advance value-based care.
Dr. Tamara Sunbul, chair of HIMSS Middle East Community and a digital health transformation and innovation strategic advisor, discusses HIMSS Executive Sumit in Dubai, creating the agenda and what leaders can learn from the Middle East region.
AI models have demonstrated up to 96.9% accuracy in screening ADHD, according to the Yonsei University study.
Health IT success is achieved by ensuring data is relevant and timely and developing insights that people need and assuring those insights are reaching people, says Ardent Health's chief digital and transformation officer Anika Gardenhire, RN.
Also, an AI-powered breath test for diagnosing silicosis has been developed in Sydney.